Eads & Heald Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,649
Closed -$237K 135
2018
Q3
$237K Sell
2,649
-260
-9% -$23K 0.14% 121
2018
Q2
$231K Sell
2,909
-2,110
-42% -$175K 0.14% 122
2018
Q1
$448K Sell
5,019
-4,282
-46% -$411K 0.28% 107
2017
Q4
$971K Sell
9,301
-2,762
-23% -$312K 0.57% 84
2017
Q3
$1.76M Buy
12,063
+1,065
+10% +$145K 1.09% 37
2017
Q2
$1.43M Sell
10,998
-97
-0.9% -$11.9K 0.92% 49
2017
Q1
$1.38M Buy
11,095
+1,159
+12% +$139K 0.89% 56
2016
Q4
$1.15M Buy
9,936
+2,237
+29% +$249K 0.78% 65
2016
Q3
$805K Buy
7,699
+25
+0.3% +$2.71K 0.55% 80
2016
Q2
$757K Sell
7,674
-135
-2% -$14K 0.52% 80
2016
Q1
$782K Buy
7,809
+1,565
+25% +$161K 0.54% 82
2015
Q4
$748K Buy
6,244
+85
+1% +$9.83K 0.52% 82
2015
Q3
$666K Buy
+6,159
New +$764K 0.48% 87

Other funds holding CELG

Eads & Heald Wealth Management's CELG Position: Q4 2018 in Review

Eads & Heald Wealth Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,649 shares — an estimated $237K sold.

Eads & Heald Wealth Management first reported a position in CELG in Q3 2015 and held it in 13 quarters. The position peaked at $1.76M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Eads & Heald Wealth Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 2,649 Celgene Corp shares in Q4 2018, an estimated $237K.
  • Eads & Heald Wealth Management first reported a position in Celgene Corp in Q3 2015 and held it in 13 quarters.
  • Eads & Heald Wealth Management's Celgene Corp position peaked at $1.76M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2018, filed 31 Jan 2019.